CPF Texas’s Kyntra Bio KYNB Stock Holding History

CPF Texas’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$6K	Hold	4	–	–	﹤0.01%	257
2018 Q2	$6K	Hold	4	–	–	﹤0.01%	217
2018 Q1	$5K	Hold	4	–	–	﹤0.01%	216
2017 Q4	$5K	Buy	+4	New	+$5.02K	﹤0.01%	246

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CPF Texas's KYNB Position: Q3 2018 in Review

CPF Texas held its Kyntra Bio (KYNB) position steady in Q3 2018 at 4 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

CPF Texas first reported a position in KYNB in Q4 2017 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold KYNB as of Q3 2018.

CPF Texas held 4 shares of Kyntra Bio worth $6K as of Q3 2018.
CPF Texas left its Kyntra Bio share count unchanged in Q3 2018.
Kyntra Bio made up ﹤0.01% of CPF Texas's portfolio in Q3 2018, its #257 holding.
CPF Texas first reported a position in Kyntra Bio in Q4 2017 and has held it in 4 quarters since.
187 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2018.

Based on CPF Texas's 13F filing for Q3 2018, filed 14 Nov 2018.